<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drugs_disease_country/PMC7265527/results/search/country/results.xml">
  <result pre="a new oral antiviral, baloxavir (Xofluza), was approved in the" exact="United States" post="for use in adults4. Baloxavir inhibits an early step"/>
  <result pre="fit our model to the 2017–2018 influenza epidemic in the" exact="United States," post="a severe epidemic which resulted in an estimated 63.3"/>
  <result pre="data from the 2016–2017 and 2018–2019 influenza seasons in the" exact="United States" post="(Supplementary Figs. 4 and 5). For each intervention scenario"/>
  <result pre="can significantly mitigate the burden of seasonal influenza in the" exact="United States." post="Using an influenza transmission model fitted to a recent"/>
  <result pre="incidence, corresponding to ~15 million infected cases averted in the" exact="United States," post="potentially saving ~4200 lives. With a higher treatment rate"/>
  <result pre="for the 2016–2017, 2017–2018, and 2018–2019 influenza seasons in the" exact="United States" post="to estimate seasonal transmission parameters (Table 1 and Supplementary"/>
  <result pre="expected number of cases averted on a national-scale in the" exact="United States," post="we multiply the median value of di/I0 by a"/>
 </snippets>
</snippetsTree>
